If curing stage IV breast cancer isn't a compelling hook... Eric has the team, persistence, and unique approach to tackle a $75b/year market opportunity (US alone). He's facing a chicken-or-egg problem in that top tier VC's think they're a bit early too invest but need funding to complete 6-12 months of studies before beginning human trials.
- 1 reply
- 1 recast
- 2 reactions
who wants to get paid $200k+ to tell Luka he’s fat?
- 1 reply
- 1 recast
- 5 reactions
chet holmgren, ladies and gentlemen
- 1 reply
- 0 recasts
- 6 reactions
